Table 3 Multivariate analysis of patients’ survival
From: COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
Regression coefficient | SE | Relative risk (RR) | 95.0% CI for RR | P | ||
|---|---|---|---|---|---|---|
Lower | Upper | |||||
TNM stage | 0.514 | 0.088 | 1.672 | 1.407 | 1.987 | 0.009* |
Relapse | −0.780 | 0.586 | 0.458 | 0.145 | 1.446 | 0.183 |
Lymph node | 0.434 | 0.406 | 1.544 | 0.696 | 3.425 | 0.285 |
ETV1 | 0.405 | 0.158 | 1.502 | 1.100 | 2.044 | 0.028* |
COP1 | −0.431 | 0.753 | 0.650 | 0.149 | 6.732 | 0.000* |
Age | 0.291 | 0.268 | 1.338 | 0.792 | 2.261 | 0.276 |
Tumor size | 0.449 | 0.610 | 1.566 | 0.474 | 5.175 | 0.462 |
Pathological type | 0.857 | 0.677 | 2.357 | 0.626 | 8.879 | 0.205 |